## SIGNATURES 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized. 

Date: March 11, 2020 

## CITIZENS, INC. 

By: /s/ Geoffrey M. Kolander 

By: /s/ Jeffery P. Conklin 

## POWER OF ATTORNEY 

Geoffrey M. Kolander, President, Chief Executive Officer and Director (Principal Executive Officer) 

Jeffery P. Conklin, Vice President, Chief Financial Officer and Treasurer (Principal Financial and Accounting Officer) 

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Geoffrey M. Kolander and James A. Eliasberg, jointly and severally, his or her attorneys-in-fact, each with the power of substitution, for him or her in any and all capacities, to sign any amendments to this Annual Report on Form 10-K, and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, hereby ratifying and confirming all that each of said attorneys-in-fact, or his substitute or substitutes, may do or cause to be done by virtue hereof. 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities indicated and on March 11, 2020. 

Dated: March 11, 2020 

/s/ Christopher W. Claus 

Christopher W. Claus, Director 

/s/ Jerry D. Davis Jr. 

Jerry D. Davis, Jr., Chairman of the Board and Director 

/s/ Dr. E. Dean Gage 

Dr. E. Dean Gage, Director 

/s/ Francis A. Keating II 

Francis A. Keating II, Director 

/s/ Geoffrey M. Kolander 

Geoffrey M. Kolander, President, Chief Executive Officer and Director 

/s/ Dr. Terry S. Maness 

Dr. Terry S. Maness, Director 

/s/ Gerald W. Shields 

Gerald W. Shields, Vice Chairman of the Board and Director 

/s/ Dr. Robert B. Sloan, Jr. 

Dr. Robert B. Sloan, Jr., Director 

/s/ Constance K. Weaver 

Constance K. Weaver, Director 

December 31, 2019 | 10-K 114 

